Colgate-Palmolive Company (CL) currently reads Oversold on the MarketMoodz overbought/oversold meter, as of August 19, 2026. The Consumer Defensive name (Household & Personal Products) last closed at $90.87. The rating moved from Strong Oversold to Oversold on August 18, 2026.

• Public ratingOversold (as of August 19, 2026)
• Last close$90.87
• Last changeMoved from Strong Oversold to Oversold on August 18, 2026
• SectorConsumer Defensive
• IndustryHousehold & Personal Products

See all oversold Consumer Defensive stocks →

AI analysis

Colgate-Palmolive Company (CL) combines durable brands and steady cash generation with a conservative growth profile. Financial health is supported by predictable margins, strong free cash flow and a reliable dividend, but near-term margin upside is constrained by reformulation costs, input inflation and FX exposure. Competitive positioning remains solid in oral and personal care, though natural and indie entrants plus regulatory-driven ingredient changes create execution and cost risks. Near-term outlook is steady; upside requires clearer signs of margin re-leverage or acceleration in emerging-market volume.

Key factors

• Leading global oral care and personal care brands with durable brand equity and pricing power
• Consistent free cash flow generation and a shareholder-friendly capital return profile (dividends/share buybacks)
• Defensive consumer staples exposure tends to hold up in mixed macro environments, supporting earnings stability
• Ongoing need for product reformulation (clean-label) could pressure near-term margins but also creates differentiation opportunities for early movers
• Modest organic growth profile in developed markets offset by higher growth potential in select emerging markets
• Supply-chain and automation tailwinds in retail and logistics can gradually lower operating costs but are not immediate catalysts
• Low visibility on large near-term catalysts — growth is steady rather than transformatory

Risks

• Input-cost inflation (commodities, packaging) and margin compression if pricing power is constrained
• Regulatory changes (e.g., GRAS/clean-label scrutiny) that raise reformulation costs and disrupt supply chains
• Foreign-exchange volatility from significant emerging-market exposure
• Slower consumer spending or continued trade-down behavior that weakens volume in developed markets
• Intensifying competition from natural/indie brands eroding share in premium segments
• Execution risk on cost-savings and innovation programs leading to slower-than-expected margin recovery
• Reputational or litigation risks tied to ingredient safety claims

Latest MarketMoodz coverage

• Brent above $108 as PPI surge fuels inflation fears ahead of Fed2026-03-18

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.